Submit Article
Legal Analysis. Regulatory Intelligence. Jurisprudence.
Singapore

Misuse of Drugs (Authorised Dissemination or Publication of Information) Regulations 2019

Overview of the Misuse of Drugs (Authorised Dissemination or Publication of Information) Regulations 2019, Singapore sl.

Statute Details

  • Title: Misuse of Drugs (Authorised Dissemination or Publication of Information) Regulations 2019
  • Act Code: MDA1973-S521-2019
  • Type: Subsidiary Legislation (SL)
  • Authorising Act: Misuse of Drugs Act (Cap. 185), specifically section 58(1)
  • Commencement: 1 August 2019
  • Enacting Minister: Minister for Home Affairs
  • Key Provisions:
    • Section 1: Citation and commencement
    • Section 2: Definitions (including cross-references to other media/entertainment statutes)
    • Section 3: Authorised dissemination or publication of information (carve-outs from restrictions in the Misuse of Drugs Act)
  • Current Version Status: Current version as at 27 Mar 2026
  • Notable Amendments: Amended by S 481/2024 (effective 31/12/2021 and 01/06/2024)

What Is This Legislation About?

The Misuse of Drugs (Authorised Dissemination or Publication of Information) Regulations 2019 (“the Regulations”) create a targeted legal pathway for certain parties to disseminate or publish information that relates to activities involving drugs—without breaching the general prohibitions found in the Misuse of Drugs Act (“the Act”). In plain terms, the Regulations recognise that drug-related information may arise in legitimate, regulated contexts such as arts entertainment, film classification, and broadcasting services. They therefore provide “authorised” exceptions for specified persons acting within defined regulatory frameworks.

The Regulations operate as a narrow carve-out. They do not broadly legalise drug information. Instead, they address a specific compliance problem: how to allow content classification, licensing, and regulated broadcasting/entertainment processes to proceed even where the content or information may touch on matters that would otherwise be restricted under the Act.

Practically, the Regulations are best understood as a bridge between (i) the Act’s restrictions on dissemination/publication of certain drug-related information and (ii) Singapore’s separate regulatory regimes for public entertainment licensing, film classification, and broadcasting licensing. The Regulations ensure that the drug-related restrictions do not unintentionally obstruct lawful media classification and licensing activities.

What Are the Key Provisions?

Section 1 (Citation and commencement) is straightforward. It provides the formal name of the Regulations and states that they come into operation on 1 August 2019. For practitioners, this matters when assessing whether conduct occurred within the regulatory framework and whether any later amendments apply.

Section 2 (Definitions) sets up terminology used in the Regulations. The definitions are heavily cross-referenced to other statutes, reflecting the Regulations’ function as an “authorisation mechanism” within existing media and entertainment regulatory systems. Key defined terms include:

  • “arts entertainment” (meaning given by the First Schedule to the Public Entertainments Act 1958);
  • “Arts Entertainment Licensing Officer” (meaning given by section 2(1) of the Public Entertainments Act 1958);
  • “Committee of Appeal” (meaning given by section 2(1) of the Films Act 1981);
  • “distribute” and “exhibit” (both defined by section 2(1) of the Films Act 1981);
  • “film content assessor” (also defined by section 2(1) of the Films Act 1981); and
  • “Info-communications Media Development Authority” (now defined by reference to the Info-communications Media Development Authority Act 2016).

These definitions are not merely academic. They determine which persons can rely on the authorisation in section 3 and which bodies must be involved for the exception to apply (for example, whether information is provided to the correct film classification authority or assessor).

Section 3 (Authorised dissemination or publication of information) is the core operative provision. It begins with a “despite” clause: “Despite sections 11D(2) and 11P(2) of the Act”, certain persons may disseminate or publish, or cause to be disseminated or published, information (whether or not through electronic media) on carrying out activities mentioned in sections 11D(1) or 11P(1) of the Act.

In other words, section 3 overrides the Act’s restrictions for a defined set of persons, but only in relation to information connected to the specified activities. The authorisation is therefore conditional and contextual: it is not a general permission to publish drug-related content; it is a permission tied to lawful regulated processes.

Section 3 then lists five categories of authorised persons:

  • (a) Arts entertainment providers who provide arts entertainment in accordance with a public entertainment licence issued or renewed under section 8 of the Public Entertainments Act 1958.
  • (b) Persons providing information to an Arts Entertainment Licensing Officer for the purpose of classifying the content of arts entertainment under the Public Entertainments Act 1958.
  • (c) Broadcasting service providers offering free-to-air nationwide television or subscription nationwide television services in or from Singapore under a broadcasting licence granted by the Info-communications Media Development Authority under section 8 of the Broadcasting Act 1994.
  • (d) Film distributors or exhibitors who distribute or publicly exhibit any classified film within the meaning of section 2(1) of the Films Act 1981.
  • (e) Persons providing information for film classification or re-classification under the Films Act 1981, including information provided to:
    • (i) the Info-communications Media Development Authority;
    • (ii) a film content assessor; or
    • (iii) the Committee of Appeal.

Why the “despite” clause matters: The Act’s sections 11D(2) and 11P(2) presumably impose restrictions on dissemination/publication of certain information. Section 3 ensures that, for the listed persons acting within their licensing/classification roles, the Act’s prohibitions do not prevent them from doing what the media regulatory framework requires—such as submitting information for classification or broadcasting content that has been through the relevant licensing process.

Electronic media is expressly covered. Section 3 states that the information may be disseminated or published “whether or not through the use of any electronic media”. This is important for modern compliance, because it removes ambiguity about whether the authorisation is limited to print or offline contexts.

Finally, the Regulations record the making date and signatory: made on 29 July 2019 by the Permanent Secretary, Ministry of Home Affairs.

How Is This Legislation Structured?

The Regulations are compact and consist of three sections:

  • Section 1 sets out the citation and commencement date.
  • Section 2 provides definitions, largely by reference to other media and entertainment statutes.
  • Section 3 provides the operative authorisation—identifying specific persons and the regulatory contexts in which they may disseminate or publish information connected to activities covered by the Misuse of Drugs Act.

There are no Parts or schedules in the extract provided; the legislative design is intentionally narrow: it is a compliance enabling provision rather than a comprehensive regulatory code.

Who Does This Legislation Apply To?

Section 3 applies to specific categories of persons involved in regulated entertainment and media activities. In practice, this includes:

  • Providers of arts entertainment licensed under the Public Entertainments Act 1958;
  • Persons who supply information to the Arts Entertainment Licensing Officer for content classification;
  • Providers of nationwide television services licensed under the Broadcasting Act 1994;
  • Film distributors and exhibitors dealing with classified films under the Films Act 1981; and
  • Persons who provide information to the relevant film classification bodies (including the IMDA, film content assessors, and the Committee of Appeal) for classification or re-classification.

Importantly, the authorisation is not available to everyone who might disseminate drug-related information. It is limited to those who are either (i) operating under the relevant licences, or (ii) providing information to the relevant licensing/classification officers or bodies for the purpose of classification/re-classification. This “purpose” element is a key compliance gate: the information must be provided for the classification function, not for unrelated publication or marketing.

Why Is This Legislation Important?

This Regulations is important because it reduces the risk of over-enforcement or unintended criminal liability in legitimate media workflows. Without an authorisation mechanism, content producers, broadcasters, and film industry participants might face uncertainty about whether submitting materials for classification—or broadcasting content that has been classified—could trigger prohibitions under the Misuse of Drugs Act.

For practitioners advising media clients, the Regulations provide a structured defence framework: if the client falls within one of the categories in section 3 and acts within the relevant licensing/classification process, the client may disseminate or publish the relevant information despite the Act’s general restrictions.

From an enforcement and compliance perspective, the Regulations also clarify which authorities matter. The definitions and section 3 list specific bodies (Arts Entertainment Licensing Officer, IMDA, film content assessor, Committee of Appeal). This means compliance teams should document:

  • the existence and scope of the relevant licence (public entertainment licence, broadcasting licence);
  • the classification or re-classification purpose for any information submission; and
  • the identity and role of the receiving officer/body (to ensure the information was provided to the correct person for the correct regulatory purpose).

Finally, the express inclusion of electronic media ensures that the authorisation is aligned with modern distribution channels. That is particularly relevant for nationwide television services and other media dissemination practices that are inherently electronic.

  • Misuse of Drugs Act (Cap. 185) — in particular sections 11D and 11P (referenced by section 3 of these Regulations) and section 58(1) (authorising power)
  • Public Entertainments Act 1958 — including licensing of arts entertainment and definitions relevant to “arts entertainment” and the “Arts Entertainment Licensing Officer”
  • Broadcasting Act 1994 — broadcasting licences under section 8
  • Films Act 1981 — film classification, distribution/exhibition concepts, and the Committee of Appeal
  • Media Development Authority Act 2016 (as reflected in the definition of IMDA) — institutional basis for the Info-communications Media Development Authority

Source Documents

This article provides an overview of the Misuse of Drugs (Authorised Dissemination or Publication of Information) Regulations 2019 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.

Written by Sushant Shukla

More in

Legal Wires

Legal Wires

Stay ahead of the legal curve. Get expert analysis and regulatory updates natively delivered to your inbox.

Success! Please check your inbox and click the link to confirm your subscription.